- Home
- CGAU vs MMED Comparison
CGAU vs MMED Comparison
Compare CGAU & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGAU | MMED |
|---|---|---|
| Founded | 2002 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.1B |
| IPO Year | 2021 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CGAU | MMED |
|---|---|---|
| Price | $17.06 | $13.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $16.67 | ★ $22.56 |
| AVG Volume (30 Days) | ★ 1.2M | 627.8K |
| Earning Date | 04-29-2026 | 06-03-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.17 | $15.99 |
| Revenue Next Year | $13.62 | $10.00 |
| P/E Ratio | $11.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.71 | $10.65 |
| 52 Week High | $21.17 | $17.86 |
Technical Indicators
Market Signals| Indicator | CGAU | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 61.15 |
| Support Level | $16.14 | $12.80 |
| Resistance Level | $19.95 | $15.80 |
| Average True Range (ATR) | 0.64 | 0.82 |
| MACD | 0.04 | 0.29 |
| Stochastic Oscillator | 37.16 | 64.44 |
Price Performance
Historical ComparisonAbout CGAU Centerra Gold Inc.
Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.
About MMED MiniMed Group Inc. Common Stock
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.